Business club - July 22, according to the state food and drug supervision and management of the administration to mobilize the deployment, from July to December, around the focus for half a year time, across the country to carry out a to crack down on illegal drug production, to combat the illegal management of drugs, to strengthen the construction of management regulations of the drug production and drug regulatory mechanism construction as the main content of "two dozen two built" special operation. This is the national food administration of drug safety after the establishment of deployment in the field of medicine's first significant action. On July 22, 2013 9:30 in the morning, we specially invite wu zhen, deputy chief of the state food administration of drug safety at xinhua, "two dozen two built" special operation accept interview.

[host] now the food and drug safety situation of our country on the whole, is a what kind of "two dozen two built" can achieve what kind of effect?

[wu] drug safety stable overall situation. After GMP implementation, pharmaceutical production scale was significantly improve, drug quality and management level of ascension, especially in the new revision of the GMP and the world health organization (who) and the standard of developed countries is almost close to the protection of such drugs is not a problem. In recent years, we are perfecting a variety of management practices at the same time, also in stepping up its drugs to sample and test of the products on the market greatly, found that drug inside some of the problems. We also increase the monitoring of adverse drug reactions, drug in use process happen some adverse reactions associated with drug we all want to capture this information in time, if there is a problem is the production process of looking for responsibility, if it is the drug itself, how do we want to remind the public attention. Drugs also exists some problems inside, there are some fake problem, that is why we want to "play". The "two dozen two built" aims to crackdown on fake and shoddy, preventing drug safety process of some systemic risks that may occur.